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Abstract 
Background: Insulin resistance (IR) in humans is related to hypertension and impaired vasodilation. Insulin adminis-
tration has been shown to lower blood pressure both in insulin resistant as well as in insulin sensitive individuals. The 
aim of the study was to investigate the association between insulin sensitivity and alterations in blood pressure in 
healthy horses before and after a euglycemic-hyperinsulinemic clamp (EHC). A 3-h EHC was performed in 13 healthy 
horses (11 mares, 2 geldings). Blood samples for measurement of plasma glucose and insulin were collected before 
the start of the EHC, every 10 min during the EHC and immediately after the EHC. Mean, systolic- and diastolic blood 
pressure was measured before and during the final 10 min of the EHC using an indirect high-definition oscillometric 
monitor (HDO, horse model) applied to the middle of the coccygeal artery. Five consecutive measurements were 
made in each horse and on each occasion. Insulin and glucose data from the EHC were used to calculate the mean 
rate of glucose disposal per unit of insulin during steady state (M/I ratio). Insulin resistance was defined as a M/I ratio 
<5 mg/kg/min/mUL (Lindåse et al. in Am J Vet Res 77:300–309, 2016).
Results: Insulin administration decreased systolic, diastolic and mean arterial pressure in all horses. The M/I ratio 
for all horses was negatively correlated with the decrease in systolic blood pressure (r2 = 0.55, P = 0.004) and mean 
arterial pressure (r2 = 0.31, P = 0.048) but not diastolic blood pressure (r2 = 0.12, P = 0.26). Eight horses were defined 
as insulin resistant (IR) and five horses had normal insulin sensitivity. The five horses with normal insulin sensitiv-
ity showed a greater decrease in systolic blood pressure (−17.0 ± 7.4 vs. −3.4 ± 4.6 mmHg, P = 0.001) and MAP 
(19.2 ± 14.7 vs. 6.9 ± 8.7 mmHg, P = 0.04) than IR horses. There was no difference in the decrease in diastolic blood 
pressure between groups (16 ± 12.8 vs. 8.9 ± 12.1 mmHg, P = 0.17).
Conclusions: This study indicates that there is a relationship between insulin sensitivity and systolic and MAP in 
horses. However, studies on a larger number of horses are needed to confirm this association.
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Background
Insulin is an important anabolic hormone, especially 
when it comes to glucose metabolism, but it also has 
important cardiovascular regulatory properties that help 
to regulate blood pressure during normal physiological 
conditions [1–3]. Insulin can act both as a vasodilator 
and a vasoconstrictor by acting at different levels of the 
cardiovascular system [1, 2]. For instance, insulin stimu-
lates the sympathetic nervous system by potentiating the 
response to noradrenaline leading to vasoconstriction but 
it also potentiates vasodilation by enhancing the response 
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to acetylcholine (AC) [1]. In addition to this it also acts 
on the endothelial cells and stimulates the release of 
nitric oxide (NO) as well as endothelin (ET), where NO 
acts as a vasodilator and ET is a potent vasoconstrictor 
[2]. Moreover insulin activates the renin-angiotensin-
aldosterone system (RAAS) and thereby increases the 
retention of sodium and water in the distal tubuli of the 
nephron [1, 3]. Altogether this helps to balance blood 
pressure during normal physiological conditions.
In humans it is well known that conditions causing 
insulin resistance (IR) and hyperinsulinemia (HI) are 
associated with hypertension [4–6]. The exact mecha-
nisms behind this are not known. However, studies 
in humans and animals have indicated that IR and HI 
increase the sympathetic tone by stimulating the release 
of NA [7]. There are indications that during IR and HI 
the response to AC and the release of NO are impaired 
whereas the stimulatory effect on both ET and NA 
remains [8, 9]. There are also increasing evidence that 
obesity, which is often associated with IR, further stim-
ulates the RAAS and causes an increased retention of 
sodium and water which in turn increases the circulating 
blood volume [1, 3]. All of this promotes a rise in blood 
pressure and in the long run causes hypertension.
From human studies it is known that insulin admin-
istration lowers systemic blood pressure both in IR as 
well as insulin sensitive individuals and that this likely 
is related to a vasodilatory effect [1, 10, 11]. In many of 
these studies blood pressure was measured when insulin 
was administered during a euglycemic hyperinsulinemic 
clamp (EHC). Whether insulin administration influences 
blood pressure in horses is not known. The major aim of 
the present study was therefore to investigate the asso-
ciation between insulin administration and alterations in 
blood pressure before and after a EHC in horses. There 
are also indications that insulin resistant individuals have 
a blunted insulin induced vasodilation [12]. An additional 
aim was therefore to see if there are any indications that 
IR horses also have an altered response to the action of 
insulin.
Methods
All procedures were sanctioned by the Ethical Commit-
tee for Animal Experiments, Uppsala, Sweden (C304/12).
Horses
Thirteen horses were included in the study, 11 Stand-
ardbreds (9 mares and 2 geldings) and 2 Warmblood 
mares. The average body weight and age of the horses 
were 505 ±  49  kg (429–572) and 13 ±  4  years (6–20) 
respectively. The mean body condition score (BCS) 
was 5.5 ± 0.8 (4.5–7) on a scale from 1 to 9, where 1 is 
considered to be extremely emaciated and 9 extremely 
fat [13]. Mean Cresty Neck Score (CNS) was 2.5 ± 0.7 
(1.5–4) on a scale from 0 to 5, where 0 is no visual 
appearance of crest and 5 a crest that is so large it per-
manently falls over to one side [14]. The Standardbreds 
were all owned by the Department of Clinical Sciences 
whereas the Warmblood horses were privately owned. 
The Standardbreds were sedentary horses whereas the 
Warmbloods were riding horses that were exercised at 
a regular basis. The horses had no history of laminitis 
and none of the horses had any signs of disease upon 
the clinical examination that was performed before the 
start of the study. All horses were kept in box stalls with 
a daily turnout in a paddock. The horses were accli-
matised to the environment and were accustomed to 
the HDO monitor (high definition oscillometry moni-
tor, horse model) by applying the device to the tail 
once daily on two consecutive days prior to the EHC. 
The Warmblood horses underwent an acclimatisation 
period of 3 days before the experiment. All horses had 
ACTH concentrations within the normal reference 
range for the season (<7 pmol/L).
Experimental design
EHC
The day before the EHC, the horses were weighed, and 
catheters (2.0  ×  105  mm Vygon, Ecouen, France) were 
introduced into both jugular veins after clipping and 
antiseptic preparation. One of the catheters was used for 
infusion of glucose and insulin and the other for the col-
lection of blood samples. The horses were kept off feed 
for 12 h before the start of the EHC but were allowed free 
access to water.
Blood samples for analysis of plasma glucose and insu-
lin were collected before the start of the EHC (−10, −5, 
and −1  min). The horses then received a continuous 
infusion of insulin (Humulin Regular, Eli Lilly Sweden 
AB, Solna, Sweden) at a rate of 3  mU/kg/min together 
with a 50  % solution of glucose, were the infusion rate 
was adjusted in order to keep blood glucose at a eugly-
cemic level (defined as 5  mmol/L). Blood glucose was 
analysed every 5 min throughout the EHC using a hand 
held glucometer (Accu-Check Aviva, Roche Diagnostics 
Scandinavia AB, Bromma, Sweden) previously validated 
(in house) for use in horses. The glucose infusion rate 
was adjusted if the blood glucose concentration deviated 
by more than 0.2 mmol/L from euglycemia. Blood sam-
ples were collected before the start of the EHC (−10 and 
−1  min), every 10-min throughout the EHC for subse-
quent determination of plasma glucose (10 min intervals) 
and plasma insulin (20 min intervals). The blood samples 
were kept on ice until centrifuged at 2770×g for 10 min 
(2770×g), within 15  min after sampling, and stored at 
−80 °C until analysis.
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Blood pressure
Blood pressure recordings were obtained once before and 
during the last 10 min of the EHC with the horses stand-
ing in the box stall. Mean arterial- (MAP), systolic-, and 
diastolic blood pressure was measured with the horse 
in confinement of the box stall, using an indirect oscil-
lometric device; HDO (Memo Diagnostic High Defini-
tion Oscillometry Monitor, horse model, S + B medVET 
GmbH, Babenhausen, Germany) applied to the middle 
of the coccygeal artery. This device has previously been 
evaluated for use in horses [15–17]. Five consecutive 
measurements were made. In each horse, the lowest and 
highest recorded value of the five consecutive blood pres-
sure determinations were excluded and the mean, sys-
tolic and diastolic pressure was calculated from the three 
remaining determinations.
Analysis
Insulin resistance was defined as a M/I ratio <5  mg/kg/
min × 103/mUL [18]. Plasma glucose concentrations were 
measured with an enzymatic method using an automated 
clinical chemistry analyzer (YSI 2300 Stat Plus Analyzer, 
YSI Incorporated, Yellow Spring, Ohio). Plasma insulin 
concentrations were analysed with a commercially available 
ELISA for humans (Mercodia Insulin ELISA, Mercodia 
AB, Uppsala, Sweden) and a commercial insulin control kit 
[Mercodia Diabetes Antigen Control (Low, High)/Human, 
Mercodia AB, Uppsala, Sweden] horses [19]. All analyses 
of plasma glucose and insulin were performed in duplicate. 
The mean intra-assay CVs for glucose was 0.5  %, and for 
insulin 3.3 %, as determined from duplicate analyses.
Calculations and statistics
All data were analysed using the mixed model proce-
dure in JMP® Pro 11.0.0. (SAS Institute Inc., Cary, NC, 
USA). Results are expressed as mean ± SD. The change 
in blood pressure before and after the EHC was analysed 
using a paired t test. Regression analysis was performed 
and the correlation coefficient was calculated according 
to the method of Pearson. The residuals were normally 
distributed. A value of P  <  0.05 was considered statisti-
cally significant.
The first 120 min of the EHC were considered an equi-
libration period. Data from the final 60 min (steady-state) 
was used for calculations of M and M/I ratio.
The M value was calculated for each 10-min interval by 
the following equation:
where GIR is the glucose infusion rate and SC is the space 
correction. The M is the mean of the six M values for 
each 10-min interval during steady state. The space cor-
rection represented an adjustment for glucose that has 
M = GIR− SC,
been added to or removed from the glucose space other 
than by metabolism.
The SC was calculated from the equation:
where G1 and G2 are plasma glucose concentrations at 
the beginning and end of the time interval, T is the time 
interval (10 min).
The M/I ratio was calculated for each 20-min interval 
where I is the plasma insulin concentration for the inter-
val. The M/I ratio is the mean of the three M/I ratios for 
each 20-min interval during steady state.
Results
Preprandial insulin concentrations were 9.3 ± 5.2 mU/L 
and glucose 5.2  ±  0.7  mmol/L. The horses had M val-
ues of on average 3.1 ± 0.8 mg/kg/min and M/I ratios of 
5.3 ± 0.6 (mg/kg/min × 103)/(mU/L).
Blood pressure and insulin administration
Resting mean values was 113  ±  11  mmHg for systolic 
blood pressure, 69 ± 13 mmHg for diastolic blood pres-
sure and 87 ±  16  mmHg for MAP for all horses. Insu-
lin administration decreased systolic- (104  ±  7  mmHg, 
P =  0.004), diastolic- (57 ±  10  mmHg, P =  0.006) and 
MAP (75 ± 8 mmHg, P = 0.006) in all horses. The M/I 
ratio for all horses was negatively correlated with the 
decrease in systolic blood pressure (r2 = 0.55, P = 0.004) 
and MAP (r2 = 0.31, P = 0.048) but not diastolic blood 
pressure (r2 = 0.12, P = 0.26), see Fig. 1. This means that 
55  % of the decrease in systolic blood pressure could 
be related to the effects of insulin in this situation. An 
increase in M/I ratio with one unit caused a decrease in 
blood pressure of 3.74 mmHg. The M value for all horses 
also showed a negative correlation with the decrease in 
systolic- (r2 = 0.37, P = 0.027) and MAP (0.31, P = 0.049) 
but not diastolic blood pressure (r2 = 0.08, P = 0.36),
Eight horses were defined to be insulin resist-
ant [M/I ratio 4.2  ±  0.6 (mg/kg/min  ×  103)/(mU/L)] 
and five horses were defined as insulin sensitive [M/I 
index 7.2  ±  1.0 (mg/kg/min  ×  103)/(mU/L)]. The five 
horses with normal insulin sensitivity showed a greater 
decrease in systolic blood pressure (−17.0  ±  7.4 vs. 
−3.4  ±  4.6  mmHg, P  =  0.001) and MAP (19.2  ±  14.7 
vs. 6.9  ±  8.7  mmHg, P  =  0.04) than IR horses. There 
was no difference in the decrease in diastolic blood pres-
sure between groups (16 ±  12.8 vs. 8.9 ±  12.1  mmHg, 
P = 0.17).
Discussion
This study shows that systolic, diastolic as well as MAP 
decreased in horses during insulin administration when 
blood glucose was kept at a euglycemic level. This is 
SC = (G2− G1)× 0.19
/
T,
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in agreement with previous studies in humans where 
decreased blood pressures were seen in association 
with insulin administration [11, 20]. The reason for the 
decrease in blood pressure in the present study is not 
known but previous studies in humans and dogs have 
shown that insulin administration promotes peripheral 
vasodilation [1, 10, 11, 20, 21]. As the horses in the pre-
sent study showed no signs of anxiety and were accus-
tomed to blood pressure recordings it is reasonable to 
assume that the decrease seen in blood pressure at the 
end of the EHC is the result of insulin induced vasodila-
tion. However, in some of the previously mentioned stud-
ies no change in blood pressure was seen after insulin 
administration despite marked vasodilation [10, 13]. The 
reason for this discrepancy in results could be the highly 
variable vasodilatory effect of insulin seen between dif-
ferent individuals [10, 22]. Blood pressure was measured 
using a non-invasive technique, a method that that is 
likely to give more heterogeneous results than an inva-
sive measurement and this could of course also influence 
the obtained results. The degree of vasodilation is also 
dependent on the dosage and duration of insulin admin-
istration as well as the insulin sensitivity of the stud-
ied individual. The time course of insulin’s action from 
administration to the onset of vasodilation also varies 
depending on the dosage used. Most studies have used an 
insulin infusion rate of 1 mU/kg/min in order to achieve 
circulating insulin concentrations of 70–100  μU/ml and 
with this infusion rate it takes 40–60  min to get half-
maximal rates of blood flow [23]. In the present study, 
a higher infusion rate (3 mU/kg/min) was used which is 
likely to have caused an earlier onset of vasodilatation. It 
is therefore reasonable to assume that changes in blood 
pressure could have occurred earlier during the EHC 
in the horses in the present study but as blood pressure 
measurements were only made during the last 10 min of 
the EHC and not repeatedly during the EHC this cannot 
be verified.
This study also indicates that horses with insulin resist-
ance, in similarity to humans, have a altered response 
to the cardiovascular effects of insulin [11]. However, 
the study is done on a small number of horses and the 
fact that blood pressure was only measured once during 
the EHC warrants studies in a larger number of horses 
and using more frequent blood pressure recordings. In 
humans, the association between IR is stronger for dias-
tolic than for systolic blood pressure whereas in horses, 
the correlation was strongest for IR and systolic blood 
pressure and no correlation was found between IR and 
the decrease in diastolic pressure [11]. The reason for this 
discrepancy in results is likely related to that the diastolic 
pressure is a reflection of a change in laminar flow that 
is more difficult to detect than systolic blood pressure, 
especially in animals that have hair coating and a thicker 
skin than humans. This is supported by the results from 
a previous study using the HDO device were the CV was 
Fig. 1  Relationship between the change in (delta) values for systolic- 
(upper panel), diastolic- (middle panel) and MAP- (lower panel) pressure 
and insulin sensitivity (M/I ratio) in 13 healthy horses before and after 
a euglycemic hyperinsulinemic clamp, P ≤ 0.05
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higher for the diastolic- than the systolic blood pressure 
measurements [15].
To our knowledge, this is the first in  vivo study that 
indicates that horses with IR have a decreased vasodila-
tory response to insulin but it does not explain the mech-
anisms that cause this altered cardiovascular response as 
this is beyond the scope of this study. There are however 
in  vitro studies performed on vessels from euthanized 
horses that have looked at the cardiovascular effects of 
insulin on vessel function [24–27]. These studies have 
shown that insulin causes vasorelaxation and that short-
term hyperinsulinemia induces an altered vascular relax-
ation response [24–26]. In  vivo studies in humans and 
animals have indicated that IR and HI increase the sym-
pathetic tone by stimulating the release of NA [7]. There 
are indications that during IR and HI states the response 
to AC and the release of NO are impaired whereas the 
stimulatory effect on both ET and NA remains [8, 24]. 
There are also increasing evidence that obesity, which is 
often associated with IR, further stimulates the RAAS 
and causes an increased retention of sodium and water 
which in turn increases the circulating blood volume.
All of these factors promote a rise in blood pressure and 
in the long run cause hypertension. An altered vascular 
response to insulin leading to an increase in vascular tone 
could perhaps explain the described increase in systemic 
blood pressure seen in previously laminitic ponies [28]. 
None of the horses were hypertensive although they had 
varying degree of insulin sensitivity. This is likely related 
to the fact all of the horses were healthy and of breeds 
with no known predisposition for IR but with varying 
degree of IR due to inactivity. In humans it is discussed 
that both the degree of insulin sensitivity and the level 
of hyperinsulinemia may affect blood pressure through 
separate pathways. Consequently, the actual blood pres-
sure levels will depend on which pressor or depressor 
action of insulin is resistant or sensitive. There are studies 
that have implied that IR and not HI is associated with 
hypertension in healthy individuals and individuals with 
diabetes, and that blood pressure is lower in IR individu-
als with HI than IR normoinsulinemic individuals [5, 6, 
29]. None of the horses in the present study were HI but 
all had varying degree of IR, which could imply that the 
mechanism is different in horses compared to man. How-
ever, studies on a larger group of horses are needed to 
confirm this.
Conclusions
This study indicates that there is a relationship between 
insulin sensitivity and systolic and MAP in horses. How-
ever, studies on a larger number of horses are needed to 
confirm this association.
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